Investors weighing AFL against GNW are effectively comparing two very different corners of the insurance industry. Aflac is a mature, dividend-paying supplemental insurer with a dominant franchise in Japan, while Genworth Financial is a holding company whose value is anchored by its majority ownership of Enact, a leading U.S. mortgage insurer. This stock comparison is most relevant for investors deciding between a steady, income-oriented name and a more contrarian, capital-return-driven opportunity. Understanding each company's relative performance, growth drivers, and risk factors can clarify how they fit within a diversified financials allocation in the current market environment.
Aflac Incorporated is a Fortune 500 supplemental health and life insurer operating through two primary segments: Aflac Japan, its largest and most profitable unit, and Aflac U.S. In recent weeks, AFL shares have traded in the low-to-mid $110s to roughly $118, with a 52-week gain in the low double digits that has trailed the broader S&P 500 but outpaced the financial-sector benchmark. The stock's relative performance reflects a balance of steady capital returns and persistent concerns around net premium erosion, which has declined at a modest annual rate over the past five years.
Recent market activity has been shaped by mixed analyst sentiment, with a consensus "Hold" rating and price targets concentrated near the current share price. The company continues to return capital aggressively, repurchasing about $1 billion in shares and paying dividends in its most recent quarter, while advancing new product rollouts in Japan. Key influences on sentiment include a weaker yen/dollar exchange rate that pressures reported results, fluctuating investment income, and recurring attention to cybersecurity-related risk disclosures. Aflac's strong adjusted return on equity and lengthy dividend-growth record remain the primary sources of investor confidence.
Genworth Financial is a Richmond, Virginia-based holding company whose family of brands includes CareScout, the Genworth name, and Enact. Its financial results are dominated by Enact, a major U.S. private mortgage insurer in which Genworth holds a roughly 81% stake, alongside a legacy long-term care and life insurance "Closed Block" that is managed for self-sustainability. In recent weeks, GNW shares have traded near the high single digits, exhibiting choppier momentum than AFL, with periods of sharp moves tied to buyback announcements, macroeconomic data, and litigation developments.
Genworth's recent results have been driven by Enact, which has generated solid adjusted operating income and a strong PMIERs (Private Mortgage Insurer Eligibility Requirements) sufficiency ratio well above regulatory minimums. The company has leaned heavily on share repurchases, executing hundreds of millions of dollars in buybacks under its program, and has announced an expanded repurchase authorization. CareScout, a capital-light aging-care services platform, represents the company's long-term growth initiative but remains an investment phase. Sentiment is tempered by legacy long-term care exposure and a valuation that trades above typical insurance-industry multiples on a price-to-earnings basis.
For traders seeking a more systematic approach to names like AFL and GNW, Tickeron's Trending AI Robots page offers a curated view of the platform's AI trading bots. Tickeron maintains hundreds of AI Trading Bots that collectively trade thousands of different tickers, yet only a select group earns placement in this featured section — those judged best suited to prevailing market conditions. Each bot operates with its own trading style, strategy, timeframe, performance record, and basket of tickers, giving users a range of approaches from short-term momentum to longer-horizon trend following. Exploring the Trending AI Robots section can help traders identify automated strategies aligned with their own objectives and risk tolerance.
The core contrast between these two stocks lies in business model and market positioning. AFL is a direct operator with deep geographic concentration in Japan, generating dependable premiums and returning cash through dividends and buybacks. GNW, by contrast, functions more as a conglomerate whose value is tied to a publicly traded subsidiary (Enact) and an emerging services platform, with capital returned mainly through repurchases.
Growth drivers differ as well. AFL's outlook hinges on new product traction in Japan and U.S. voluntary benefits, offset by currency headwinds and gradually declining earned premiums. GNW's story is more event-driven, depending on Enact's mortgage-insurance cycle, buyback execution, and CareScout's expansion — along with the potential outcome of litigation recoveries. On the risk side, AFL's stability is countered by Japan concentration and foreign-exchange sensitivity, while GNW carries legacy long-term care liabilities and a richer relative valuation. Market sentiment currently treats AFL as a defensive, income-oriented holding and GNW as a higher-beta, value-and-catalyst play, making the two suitable for different investor profiles within a financials allocation.
Based on observable factors, Tickeron's AI would likely lean toward AFL in the current environment. The stock's trend consistency, strong capital position, dependable dividend record, and more stable price behavior stand in contrast to GNW's choppier momentum and dependence on discrete catalysts. That said, GNW's aggressive buyback program and potential litigation upside could appeal to AI strategies oriented toward higher volatility and event-driven returns. In probabilistic terms, AFL appears better positioned for trend-following and stability-focused models, while GNW may register more favorably within mean-reversion or momentum strategies that tolerate greater price swings. Neither profile is categorically superior; the appropriate choice depends on the strategy's timeframe and risk framework.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
AFL saw its Momentum Indicator move above the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned positive. In 47 of the 76 cases, the stock moved higher in the following days. The odds of a move higher are at 62%.
The Moving Average Convergence Divergence (MACD) for AFL just turned positive on October 07, 2026. Looking at past instances where AFL's MACD turned positive, the stock continued to rise in 26 of 46 cases over the following month. The odds of a continued upward trend are 57%.
AFL moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AFL crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +2.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where AFL advanced for three days, in 200 of 366 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
The Aroon Indicator entered an Uptrend today. In 141 of 277 cases where AFL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 51%.
The 10-day RSI Indicator for AFL moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 21 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 52%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 30 of 64 cases where AFL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 47%.
AFL broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 33 (best 1 - 100 worst), indicating outstanding price growth. AFL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.052) is normal, around the industry mean (1.337). P/E Ratio (13.325) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (0.463). Dividend Yield (0.020) settles around the average of (0.047) among similar stocks. AFL's P/S Ratio (3.313) is slightly higher than the industry average of (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Be on the lookout for a price bounce soon.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GNW's RSI Indicator exited the oversold zone, 17 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for GNW just turned positive on October 28, 2026. Looking at past instances where GNW's MACD turned positive, the stock continued to rise in 35 of 48 cases over the following month. The odds of a continued upward trend are 73%.
Following a +2.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where GNW advanced for three days, in 208 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GNW as a result. In 49 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
GNW broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GNW entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 14 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: GNW's P/B Ratio (0.377) is slightly lower than the industry average of (1.337). P/E Ratio (16.415) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (0.463). Dividend Yield (0.046) settles around the average of (0.047) among similar stocks. P/S Ratio (0.562) is also within normal values, averaging (1.303).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 54 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. GNW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
AFL | GNW | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 40 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | 34 Fair valued | |
PROFIT vs RISK RATING 1..100 | 3 | 14 | |
SMR RATING 1..100 | 94 | 93 | |
PRICE GROWTH RATING 1..100 | 33 | 60 | |
P/E GROWTH RATING 1..100 | 59 | 54 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GNW's Valuation (34) in the Life Or Health Insurance industry is somewhat better than the same rating for AFL (77). This means that GNW’s stock grew somewhat faster than AFL’s over the last 12 months.
AFL's Profit vs Risk Rating (3) in the Life Or Health Insurance industry is in the same range as GNW (14). This means that AFL’s stock grew similarly to GNW’s over the last 12 months.
GNW's SMR Rating (93) in the Life Or Health Insurance industry is in the same range as AFL (94). This means that GNW’s stock grew similarly to AFL’s over the last 12 months.
AFL's Price Growth Rating (33) in the Life Or Health Insurance industry is in the same range as GNW (60). This means that AFL’s stock grew similarly to GNW’s over the last 12 months.
GNW's P/E Growth Rating (54) in the Life Or Health Insurance industry is in the same range as AFL (59). This means that GNW’s stock grew similarly to AFL’s over the last 12 months.
| AFL | GNW | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 52% | 2 days ago 68% |
| Stochastic ODDS (%) | 2 days ago 47% | 2 days ago 77% |
| Momentum ODDS (%) | 3 days ago 62% | 2 days ago 64% |
| MACD ODDS (%) | 6 days ago 57% | 2 days ago 73% |
| TrendWeek ODDS (%) | 2 days ago 57% | 2 days ago 57% |
| TrendMonth ODDS (%) | 2 days ago 53% | 2 days ago 49% |
| Advances ODDS (%) | 2 days ago 55% | 8 days ago 66% |
| Declines ODDS (%) | N/A | 6 days ago 58% |
| BollingerBands ODDS (%) | 2 days ago 48% | 2 days ago 67% |
| Aroon ODDS (%) | 2 days ago 51% | 2 days ago 39% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AFL’s FA Score shows that 2 FA rating(s) are green while GNW’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AFL’s TA Score shows that 6 TA indicator(s) are bullish while GNW’s TA Score has 4 bullish TA indicator(s).
AFL (@Life/Health Insurance) experienced а +2.10% price change this week, while GNW (@Life/Health Insurance) price change was -3.77% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.54%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was -0.73%.
AFL is expected to report earnings on Feb 03, 2027.
GNW is expected to report earnings on Feb 24, 2027.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
A.I.dvisor indicates that over the last year, AFL has been loosely correlated with CNO. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AFL jumps, then CNO could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CCSB | 19.52 | -0.11 | -0.59% |
| Carbon Collective Short Duration Green Bond ETF (CCSB) | |||
| ZTR | 6.53 | -0.06 | -0.91% |
| Virtus Total Return Fund | |||
| BULZ | 23.73 | -0.42 | -1.74% |
| MicroSectors Solactive FANG & Innovation 3X Leveraged ETN (BULZ) | |||
| ETHV | 30.02 | -1.02 | -3.29% |
| VanEck Ethereum ETF (ETHV) | |||
| INFH | 3.36 | -0.24 | -6.67% |
| Defiance Daily Target 2X Long INFQ ETF (INFH) | |||